Dr. Cara Marie Govednik, MD

Dr. Govednik practices at Baylor Scott & White Medical Center - Grapevine in Grapevine, Texas, part of Baylor Scott & White Health.

Dr. Govednik's NPI, 1356507396, was assigned on July 30, 2008. Dr. Govednik graduated from Joe R. & Teresa Lozano Long School of Medicine in 2008. Dr. Govednik holds Texas license P5633.

Dr. Govednik's primary practice is Baylor Scott & White Medical Center - Grapevine, at 1650 W College St, Grapevine, TX 76051 in Tarrant County. The practice phone is (817) 481-1588.

Dr. Govednik's primary practice is Baylor Scott & White Medical Center - Grapevine in Grapevine, Texas, part of Baylor Scott & White Health. Dr. Govednik is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. Govednik to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Govednik practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Govednik's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Govednik is board certified in surgery by the American Board of Surgery. Dr. Govednik is licensed in Texas.

Dmand AI lists colon removal, gallbladder removal, mastectomy and thyroid surgery among the conditions Dr. Govednik treats.

CMS data shows 209 Medicare services from Dr. Govednik across 6 procedure codes in 2024, for 141 Medicare patients. Medicare paid $29,287 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 141 Medicare patients who saw Dr. Govednik in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Govednik's median patient age at 63, with 65% women.

In 2024, Dr. Govednik wrote 53 Medicare Part D claims for 43 patients. 91% of them were for generic drugs. CMS names the drug for 39 of them, across 2 drugs with 11 or more claims each, at $199 in total drug cost. In 2023, CMS named 72 claims across 2 drugs.

Dr. Govednik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of mastectomy by Dr. Govednik, more than 66% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Govednik, published from 2014 to 2016. 2014 was the busiest year, with 4. The most frequent topics are Parathyroidectomy, Thyroidectomy and Minimally Invasive Surgical Procedures. Dr. Govednik has published most often in Surgery. Dr. Govednik's most frequent co-authors are Samuel K. Snyder, MD, Terry C. Lairmore, MD and John C. Hendricks, MD.

CMS Open Payments shows 48 general payments to Dr. Govednik from 16 drug and device companies from 2016 to 2025. Education make up the largest share, 52% of the total. Intuitive Surgical, Inc. paid the most, $5,063.

Dmand AI lists 1 award for Dr. Govednik.

Dr. Govednik graduated from Joe R. & Teresa Lozano Long School of Medicine in 2008. Dr. Govednik is a member of ACS.

Dr. Govednik is in network with 20 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.